adenosine monophosphate has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
| Herzer, WA; Jackson, EK; Mi, Z; Swamy, RS | 1 |
| Carrier, M; DeMaria, RG; Denault, A; Desjardins, F; Fortier, S; Lamarche, Y; Malo, O; Perrault, LP | 1 |
| Chien, S; Wheeler, TJ; Wiegand, CB | 1 |
| Boyce, AM; Ferreira, CR; Gafni, RI | 1 |
1 review(s) available for adenosine monophosphate and cardiovascular agents
| Article | Year |
|---|---|
Generalized Arterial Calcification of Infancy: New Insights, Controversies, and Approach to Management.
Topics: Adenosine Monophosphate; Bone Density Conservation Agents; Calcinosis; Cardiovascular Agents; Chelating Agents; Diphosphates; Diphosphonates; Familial Hypophosphatemic Rickets; Genotype; Hearing Loss; Humans; Multidrug Resistance-Associated Proteins; Phenotype; Phosphoric Diester Hydrolases; Pseudoxanthoma Elasticum; Pyrophosphatases; Thiosulfates; Tooth Diseases; Vascular Calcification; Vitamin D | 2020 |
4 other study(ies) available for adenosine monophosphate and cardiovascular agents
| Article | Year |
|---|---|
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |
Local and systemic effects of peritoneal lavage with high concentrations of adenosine in rats.
Topics: Adenosine; Adenosine Monophosphate; Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Heart Rate; Hypoxanthine; Inosine; Male; Microdialysis; Peritoneal Lavage; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Vasoconstrictor Agents; Xanthines | 2000 |
Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
Topics: Acetylcholine; Adenosine Monophosphate; Administration, Inhalation; Animals; Antihypertensive Agents; Antioxidants; Biomarkers; Cardiopulmonary Bypass; Cardiovascular Agents; Cyclic AMP; Disease Models, Animal; Endothelium, Vascular; Epoprostenol; Female; Indoles; Lung; Lung Diseases; Male; Models, Cardiovascular; Phenylephrine; Pulmonary Artery; Pulmonary Wedge Pressure; Swine; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Fructose-1,6-bisphosphate enhances hypothermic preservation of cardiac myocytes.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Agents; Cell Death; Dichloroacetic Acid; Fructosediphosphates; Glucose; Hypothermia, Induced; Insulin; Male; Myocytes, Cardiac; Preservation, Biological; Rats; Rats, Sprague-Dawley | 2005 |